Search
for
Sort by
Research 361–390 of 520
- <i>IKZF1</i> and Ikaros Overexpression Results in Alopecia Areata‐Like Phenotype in Mice
- Hair follicle targeting via gelatin coated transferosomes loaded with tofacitinib citrate for enhanced treatment of alopecia areata: Clinical evaluation of alopecia areata patients
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- 290 Brepocitinib improves cicatricial alopecia and downregulates key T-helper biomarkers
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- 056 IKZF1 and IKAROS overexpression contributes to the pathogenesis of alopecia areata
- 1432 IL-9/IL-9R signaling as a novel regulator of human hair follicle growth and immune privilege
- A perspective on predictive markers of alopecia
- 865 Frontal fibrosing alopecia is associated with dysregulation of cholesterol biosynthesis pathways, fibrosis and mast cells
- Are Janus kinase (JAK) inhibitors beneficial in the treatment of androgenic alopecia?
- Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- The JAK/STAT signaling pathway: from bench to clinic
- Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- Skin Pigmentation Types, Causes and Treatment—A Review
- Hair follicle immune privilege and its collapse in alopecia areata
- A Subset of TREM2+ Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair Growth
- Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib
- Biomarkers of alopecia areata disease activity and response to corticosteroid treatment
- JAK Inhibitors for Treatment of Alopecia Areata
- Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention
- Age-associated inflammation connects RAS-induced senescence to stem cell dysfunction and epidermal malignancy
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells
- Resident Memory T Cells in Autoimmune Skin Diseases
- Alopecia areata: What’s new in the epidemiology, comorbidities, and pathogenesis?
- PROTACs: A novel strategy for cancer drug discovery and development
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies